Format

Send to

Choose Destination
Wien Med Wochenschr. 2013 Feb;163(3-4):102-5. doi: 10.1007/s10354-012-0166-0. Epub 2012 Dec 20.

Efficacy and safety of Echinaforce® in respiratory tract infections.

Author information

1
Allergy Clinic, Hochwangstr. 3, 7302 Landquart, Switzerland. andreas@schapowal.ch

Abstract

Echinaforce® is the standardised extract of Echinacea purpurea from Bioforce, Switzerland. Recent studies show immunomodulation and broad antiviral effects against respiratory tract viruses. Haemagglutinin and Neuraminidase are blocked. In contrast to Oseltamivir no resistance is caused by Echinaforce®. A randomised, double-blind, placebo-controlled study over four months confirms that Echinaforce® supports the immune resistance and acts directly against a series of viruses. Echinaforce® is efficacious and safe in respiratory tract infections for long-term and short-term prevention as well as for acute treatment.

PMID:
23263637
DOI:
10.1007/s10354-012-0166-0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center